59011-275 : Hysingla ER 80 mg Oral Tablet, Extended Release


NDC59011-275
Labeler: Purdue Pharma Lp
Product Type: Human Prescription Drug
Drug Name:  Hysingla ER
Dosage Form: Oral Tablet, Extended Release
Application #: NDA206627
Rev. Date: 
CSA Schedule: CII (US) [1]


[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: HYD;80
Shapes:  Round
Colors:  Pink
Size (mm): 12
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 59011-275-60: 60 TABLET, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (59011‑275‑60)

Active Ingredients:

  • Hydrocodone Bitartrate

Dosage Strength:

  • 80 mg

Inactive Ingredients:

  • Hydroxypropyl Cellulose (Type H)
  • Polyethylene Glycol 3350
  • Cellulose, Microcrystalline
  • Polysorbate 80
  • Polyvinyl Alcohol
  • Talc
  • Titanium Dioxide
  • Ferric Oxide Red
  • Magnesium Stearate
  • Polyethylene Glycols
  • Butylated Hydroxytoluene

Pharmaceutical Classes:

  • Opioid Agonist [EPC]
  • Opioid Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 59011-271 Hysingla ER 20 mg Oral Tablet, Extended Release by Purdue Pharma Lp
  • 59011-272 Hysingla ER 30 mg Oral Tablet, Extended Release by Purdue Pharma Lp
  • 59011-273 Hysingla ER 40 mg Oral Tablet, Extended Release by Purdue Pharma Lp
  • 59011-274 Hysingla ER 60 mg Oral Tablet, Extended Release by Purdue Pharma Lp
  • 59011-276 Hysingla ER 100 mg Oral Tablet, Extended Release by Purdue Pharma Lp
  • 59011-277 Hysingla ER 120 mg Oral Tablet, Extended Release by Purdue Pharma Lp

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59011-275 QR Code

< Prev: 59011-274Next: 59011-276 >

Related Discussions:

1 Tablespoon Of Hydrocodone Bitartrate And Acetaminophen Oral Solution Equals 15 Milliliters 5 What Measurment
If one Tablespoon hydrocodone Bitartrate and Acetaminophen oral solution is 15 milliliters, what mearurment is 5 millili... 5 replies
HYDROCODONEBITARTRATE
ROUND WHITE TABLET WITH K10 ON IT ## This is not Hydrocodone. The pill in description is Acetaminophen (500 mg). You can... 2 replies
hydrocodone bitartrate apap
is this med suppost to be pink ?? ## There are some that are pink, some that are white, some that are yellow…. I t... 4 replies
hydrocodone bitartrate + acetaminophen sustained release 15MG + 200 MG
purple capsule no writing I get them from my doctor and know what they are I just want more informaiton about them. I wo... 3 replies
Hydrocodone Bitartrate Wapap 5mg
extremely constipated. Have tried everything. Metamucil, Colace, Enema. Have not had a BM in in 5 days. Fractured my bac... 2 replies
hydrocodone bitartrate w apap 5 mg 325
Can I take this medication for a headache ## Hello, Sam! How are you? It is a narcotic analgesic, Hydrocodone with Aceta... 1 reply
hydrocodone bitartrateacetomenophin hydrocodone bitartrate
white oblong tablet with3592 on one side and v on the other ## Just to confirm, the pill which you are describing is Ace... 1 reply
hydrocodone bitartrate10 mg. and aceteminophen 500mg
pin with 3600 imprinted on oe side and the letter V on the other side ## The pill in description is Acetaminophen + Hydr... 1 reply
hydrocodone vs hydrocodone bitartrate
Can these be taken simultaneously? I have two separate bottles and have been advised by a friend they are the same ## He... 3 replies
Tussigon (Hydrocodone bitartrate + homatropine) : Can't Get It
For those owners in the unenviable position of needing Tussigon for their pets chronic cough: as a veterinary specialist... 13 replies




Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.